Form D · Other Health Care
RubyWell, Inc.
New York, NY · CIK 0002041478
Offering snapshot reported Oct 18, 2024 · SEC filing
- Reported sold
- $1.11M Offering amount: $3M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 18, 2024 | Initial | $1,110,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-527149
Source: Form D, filed Oct 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Julie Kennedy | Director, Executive |
| Michael Loeb | Director |
| Abigail Miller Levy | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
712 Fifth Avenue, 7 Th Floor
New York, NY, 10035
New York, NY, 10035